Interdependency of MHC Class II/Self-Peptide and CD1d/Self-Glycolipid Presentation by TNF-Matured Dendritic Cells for Protection from Autoimmunity1

Dendritic cells (DC) are key regulators of T cell immunity and tolerance. NKT cells are well-known enhancers of Th differentiation and regulatory T cell function. However, the nature of the DC directing T and NKT cell activation and polarization as well as the role of the respective CD1d Ags presented is still unclear. In this study, we show that peptide-specific CD4+IL-10+ T cell-mediated full experimental autoimmune encephalomyelitis (EAE) protection by TNF-treated semimatured DCs was dependent on NKT cells recognizing an endogenous CD1d ligand. NKT cell activation by TNF-matured DCs induced high serum levels of IL-4 and IL-13 which are absent in NKT cell-deficient mice, whereas LPS plus anti-CD40-treated fully mature DCs induce serum IFN-γ. In the absence of IL-4Rα chain signaling or NKT cells, no complete EAE protection was achieved by TNF-DCs, whereas transfer of NKT cells into Jα281−/− mice restored it. However, activation of NKT cells alone was not sufficient for EAE protection and early serum Th2 deviation. Simultaneous activation of NKT cells and CD4+ T cells by the same DC was required for EAE protection. Blocking experiments demonstrated that NKT cells recognize an endogenous glycolipid presented on CD1d on the injected DC. Together, this indicates that concomitant and interdependent presentation of MHC II/self-peptide and CD1d/self-isoglobotrihexosylceramide to T and NKT cells by the same partially or fully matured DC determines protective and nonprotective immune responses in EAE.

[1]  G. Schuler,et al.  Dendritic Cells Matured With TNF can be Further Activated In Vitro and After Subcutaneous Injection In Vivo Which Converts Their Tolerogenicity Into Immunogenicity , 2006, Journal of immunotherapy.

[2]  H. Wakao,et al.  Induction of Regulatory Properties in Dendritic Cells by Vα14 NKT Cells1 , 2005, The Journal of Immunology.

[3]  P. Verginis,et al.  Tolerogenic Semimature Dendritic Cells Suppress Experimental Autoimmune Thyroiditis by Activation of Thyroglobulin-Specific CD4+CD25+ T Cells1 , 2005, The Journal of Immunology.

[4]  C. Sousa,et al.  Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function , 2005, Nature Immunology.

[5]  R. Proia,et al.  Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.

[6]  Gabrielle T Belz,et al.  Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity , 2004, Nature Immunology.

[7]  G. Berry,et al.  Induction of T helper type 1–like regulatory cells that express Foxp3 and protect against airway hyper-reactivity , 2004, Nature Immunology.

[8]  T. Huizinga,et al.  Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells. , 2004, Arthritis and rheumatism.

[9]  Jelena S. Bezbradica,et al.  Quantitative and Qualitative Differences in the In Vivo Response of NKT Cells to Distinct α- and β-Anomeric Glycolipids1 , 2004, The Journal of Immunology.

[10]  M. Smyth,et al.  Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors , 2004, Nature Immunology.

[11]  Polly Matzinger,et al.  'Educated' dendritic cells act as messengers from memory to naive T helper cells , 2004, Nature Immunology.

[12]  I. Maričić,et al.  Prevention of Autoimmunity by Targeting a Distinct, Noninvariant CD1d-reactive T Cell Population Reactive to Sulfatide , 2004, The Journal of experimental medicine.

[13]  L. Kaer,et al.  NKT cells: what's in a name? , 2004, Nature Reviews Immunology.

[14]  L. Kaer,et al.  Quantitative and Qualitative Differences in the In Vivo Response of NKT Cells to Distinct-and -Anomeric Glycolipids , 2004 .

[15]  H. Waldmann,et al.  Serial analysis of gene expression provides new insights into regulatory T cells. , 2003, Seminars in immunology.

[16]  R. Steinman,et al.  Activation of Natural Killer T Cells by -Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein , 2003 .

[17]  G. Martino,et al.  Activation of invariant NKT cells by αGalCer administration protects mice from MOG35–55‐induced EAE: critical roles for administration route and IFN‐γ  , 2003 .

[18]  R. Locksley,et al.  Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Brenner,et al.  Understanding the function of CD1-restricted T cells , 2003, Nature Immunology.

[20]  H. Groux,et al.  Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. , 2003, Immunity.

[21]  T. Brocker,et al.  Endogenous Dendritic Cells Are Required for Amplification of T Cell Responses Induced by Dendritic Cell Vaccines In Vivo 1 , 2003, The Journal of Immunology.

[22]  A. Lanzavecchia,et al.  An Invariant vo 124-Jc ~ Q / V 311 T Cell Receptor Is Expressed in All Individuals by Clonally Expanded CD 4-8-T Cells , 2003 .

[23]  E. Grant,et al.  CD1-dependent dendritic cell instruction , 2002, Nature Immunology.

[24]  L. Kaer,et al.  IFN-γ–mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, α-galactosylceramide , 2002 .

[25]  Gerold Schuler,et al.  Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? , 2002, Trends in immunology.

[26]  G. Berry,et al.  Antigen-specific regulatory T cells develop via the ICOS–ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity , 2002, Nature Medicine.

[27]  H. Lassmann,et al.  Cutting Edge: Vα14-Jα281 NKT Cells Naturally Regulate Experimental Autoimmune Encephalomyelitis in Nonobese Diabetic Mice1 , 2002, The Journal of Immunology.

[28]  S. Sharif,et al.  Regulation of autoimmune disease by natural killer T cells , 2002, Journal of Molecular Medicine.

[29]  D. Levy Whence Interferon? Variety in the Production of Interferon in Response to Viral Infection , 2002, The Journal of experimental medicine.

[30]  D. Zélénika,et al.  Regulatory T Cells Overexpress a Subset of Th2 Gene Transcripts1 , 2002, The Journal of Immunology.

[31]  C. Bogdan,et al.  Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor α Induce Antigen-specific Protection of Mice from Autoimmunity , 2002, The Journal of experimental medicine.

[32]  I. Maričić,et al.  Activation of Natural Killer T Cells Potentiates or Prevents Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.

[33]  Michael T. Wilson,et al.  Natural Killer T Cell Activation Protects Mice Against Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.

[34]  L. Zitvogel,et al.  Dendritic Cell Maturation Overrules H-2d–Mediated Natural Killer T (Nkt) Cell Inhibition , 2001, The Journal of experimental medicine.

[35]  M. Kronenberg,et al.  Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes , 2001, Nature Medicine.

[36]  D. Umetsu,et al.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen , 2001, Nature Immunology.

[37]  Ming-Lang Zhao,et al.  Regulation of Experimental Autoimmune Encephalomyelitis in the C57BL/6J Mouse by NK1.1+, DX5+, αβ+ T Cells1 , 2001, The Journal of Immunology.

[38]  R. Fritz,et al.  Regulation of experimental autoimmune encephalomyelitis in the C57BL/6J mouse by NK1.1+, DX5+, alpha beta+ T cells. , 2001, Journal of immunology.

[39]  L. Kaer,et al.  The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice , 2001, Nature Medicine.

[40]  M. Smyth,et al.  NKT cells: facts, functions and fallacies. , 2000, Immunology today.

[41]  R. Cummings,et al.  Expression Cloning of a New Member of the ABO Blood Group Glycosyltransferases, iGb3 Synthase, That Directs the Synthesis of Isoglobo-glycosphingolipids* , 2000, The Journal of Biological Chemistry.

[42]  L. Teyton,et al.  In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers , 2000, The Journal of experimental medicine.

[43]  J. Newcombe,et al.  Differential Expression of NK T Cell Vα24JαQ Invariant TCR Chain in the Lesions of Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy1 , 2000, The Journal of Immunology.

[44]  R. Steinman,et al.  The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells , 2000, The Journal of experimental medicine.

[45]  河野 鉄 CD1d-restricted and TCR-mediated activation of V α14 NKT cells by glycosylceramides , 2000 .

[46]  M. Röllinghoff,et al.  Biologic functions and signaling of the interleukin-4 receptor complexes. , 2000, Immunobiology.

[47]  T. Kamata,et al.  Inhibition of T Helper Cell Type 2 Cell Differentiation and Immunoglobulin E Response by Ligand-Activated Vα14 Natural Killer T Cells , 1999, The Journal of experimental medicine.

[48]  L. Kaer,et al.  Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. , 1999, Journal of immunology.

[49]  H. Fujiwara,et al.  A Novel Function of Vα14+CD4+NKT Cells: Stimulation of IL-12 Production by Antigen-Presenting Cells in the Innate Immune System , 1999, The Journal of Immunology.

[50]  M. Kronenberg,et al.  Immunization with α‐galactosylceramide polarizes CD1‐reactive NK T cells towards Th2 cytokine synthesis , 1999, European journal of immunology.

[51]  A. Ohta,et al.  The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells , 1999, The Journal of experimental medicine.

[52]  D. Godfrey,et al.  α/β–T Cell Receptor (TCR)+CD4−CD8− (NKT) Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10 , 1998, The Journal of experimental medicine.

[53]  M. Wang,et al.  Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses. , 1998, Journal of immunology.

[54]  D. Hafler,et al.  Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes , 1998, Nature.

[55]  Hiroshi Sato,et al.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. , 1997, Science.

[56]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[57]  Seokmann Hong,et al.  CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. , 1997, Immunity.

[58]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[59]  R. Locksley,et al.  Beta 2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses , 1996, The Journal of experimental medicine.

[60]  A. Lanzavecchia,et al.  An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells , 1994, The Journal of experimental medicine.

[61]  H. Bluethmann,et al.  Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. , 1993, International immunology.

[62]  H. Koseki,et al.  Dominant expression of a distinctive V14+ T-cell antigen receptor alpha chain in mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.